4.55 USD
+0.13 (+2.94%)
4.6 USD
+0.05 (+1.1%)
ChartMill assigns a Buy % Consensus number of 83% to CADL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.87. This target is 314.73% above the current price.
CADL was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CADL.
In the previous month the buy percentage consensus was at a similar level.
CADL was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-14 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-28 | Stephens & Co. | Initiate | Overweight |
| 2025-10-21 | LifeSci Capital | Initiate | Outperform |
| 2025-09-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-03 | B of A Securities | Downgrade | Buy -> Neutral |
| 2025-04-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-20 | Citigroup | Initiate | Buy |
| 2025-02-19 | Canaccord Genuity | Initiate | Buy |
| 2025-02-07 | B of A Securities | Initiate | Buy |
| 2024-12-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-03-31 | Credit Suisse | Maintains | Outperform |
| 2022-12-07 | Credit Suisse | Maintains | Outperform |
| 2022-12-02 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-19 | BMO Capital | Initiate | Outperform |
| 2021-08-23 | UBS | Initiate | Buy |
| 2021-08-23 | Credit Suisse | Initiate | Outperform |
| 2021-08-23 | Jefferies | Initiate | Buy |
CANDEL THERAPEUTICS INC / CADL FAQ
What do analysts expect the price target to be for CANDEL THERAPEUTICS INC (CADL)?
14 analysts have analysed CADL and the average price target is 18.87 USD. This implies a price increase of 314.73% is expected in the next year compared to the current price of 4.55.
Can you provide the consensus rating for CANDEL THERAPEUTICS INC stock?
The consensus rating for CANDEL THERAPEUTICS INC (CADL) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.